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Abstract
Objective: Intraindividual variability (IIV) in reaction time refers to the trial-to-trial
fluctuations in responding across a given cognitive task. Cross-sectional research suggests
that IIV increases with normal and neuropathological ageing and it may serve as a marker of
neurobiological integrity. This raises the possibility that IIV may also predict future cognitive
decline and, indeed, neuropathology. Therefore, we conducted a systematic review to address
these issues.
Methods: A search of electronic databases Embase, Medline, PsycINFO and Web of Science
was completed on 17th May 2016 that identified longitudinal investigations of IIV in middle-
aged or older adults.
Results: 688 studies were initially identified of which 22 met the inclusion criteria. Nine
included longitudinal IIV measures and 17 predicted subsequent outcome (cognitive decline
or impairment, dementia, mortality) from baseline IIV. The results suggested IIV increased
over time, particularly in participants aged over 75 years. Greater baseline IIV was
consistently associated with increased risk of adverse outcomes including cognitive decline
or impairment, and mortality.
Conclusion: Increased IIV over time is associated with normal ageing. However, further
increases in IIV over and above those found in normal ageing may be a risk factor for future
cognitive impairment or mortality. Measures of IIV may therefore have considerable
potential as a supplement to existing clinical assessment to aid identification of individuals at
risk of adverse outcomes such as dementia or death.
Key words: Intraindividual variability; Ageing; Dementia; Cognitive decline; Mortality;
Longitudinal.
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It is well established that adult ageing is characterised behaviourally by increased
intraindividual variability in cognitive function. As the present review will show, such
variability is not only a feature of normal ageing, but becomes more marked in the presence
of neuropathology or impending mortality. It is likely that this widely observed behavioural
characteristic of ageing reflects greater neurobiological variability stemming from
compromised central nervous system integrity. Given the proposed neurobiological
underpinnings of IIV, the aim of the present systematic review, therefore, was to critically
evaluate the empirical literature using this marker to predict cognitive change in normal
ageing, and also age-related neuropathological outcomes including mild cognitive
impairment (MCI), dementia, Parkinson’s disease and, indeed, death. First though, we
describe some of the characteristics of this behavioural marker before detailing theoretical
and empirical linkage to potential underlying neurobiological variability.
Behavioural Intraindividual Variability
IIV refers to the within-person variation in cognitive performance. It is measured over
relatively short periods using trial-to-trial fluctuations in reaction time (RT) on a given task,
through repeated assessments over longer periods such as days or weeks, or across a battery
of different cognitive tasks measured in the same session (Hultsch, MacDonald, & Dixon,
2002). The most widely used measure of IIV is RT variability, which provides the focus for
the present review. Often, researchers have implicitly treated RT variability as random noise
or error variance and collapsed trials across a cognitive task to obtain measures of central
tendency (e.g., mean or median RT). However, theorists have suggested that this variation is
systematic and that the measure may capture meaningful information about higher-order
cognitive processes such as fluctuating attentional or executive control mechanisms (Bunce,
MacDonald, & Hultsch, 2004; Bunce, Warr, & Cochrane, 1993; West, Murphy, Armilio,
Craik, & Stuss, 2002). Moreover, research typically shows greater IIV to increase across the
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adult lifespan (Dykiert, Der, Starr, & Deary, 2012; Hultsch et al., 2002; Williams, Hultsch,
Strauss, Hunter, & Tannock, 2005). However, although it appears that IIV increases with
normal ageing, due to the cross-sectional nature of many studies, the possibility of cohort
effects cannot be ruled out.
Neuropathology and Brain Substrates of Intraindividual Variability
There is considerable empirical support for the suggestion that IIV reflects underlying
neurobiological integrity (Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000;
Hultsch, Strauss, Hunter, & MacDonald, 2008). For example, cross-sectional studies show
that relative to healthy older persons, IIV is greater in individuals living with a range of
neurodegenerative disorders including Parkinson’s disease (e.g., de Frias, Dixon, Fisher, &
Camicioli, 2007), MCI (e.g., Christensen et al., 2005; Dixon et al., 2007), and dementia (e.g.,
Gorus, De Raedt, Lambert, Lemper, & Mets, 2008; Hultsch et al., 2000), including early
stage Alzheimer’s disease (Duchek et al., 2009). However, given these findings of greater
variability in the presence of age-related neuropathology, what evidence is there of
associations between IIV and brain substrates? Several magnetic resonance imaging (MRI)
studies have identified associations between greater behavioural variability and poorer
neuroanatomical integrity as shown by reduced white matter volume (Jackson, Balota,
Duchek, & Head, 2012; Walhovd & Fjell, 2007), increased white matter hyperintensity
volume (Bunce et al., 2010; Bunce et al., 2007), and diffusion tensor imaging metrics such as
fractional anisotropy (Deary et al., 2006; Fjell, Westlye, Amlien, & Walhovd, 2011; Mella,
de Ribaupierre, Eagleson, & de Ribaupierre, 2013; Moy et al., 2011).
A plausible explanation for increases in IIV across the lifespan concerns the
possibility that age-related dopamine depletion reduces neural signal-to-noise thereby
affecting the efficiency of brain connectivity (Li, Lindenberger, & Sikstrom, 2001). Due to
the hypothesized more intermittent signalling, variability increases, a possibility that has
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received support from MRI work (e.g., MacDonald, Karlsson, Rieckmann, Nyberg, &
Backman, 2012). Additionally, with the presence of amyloid, neurofibrillary tangles and the
deterioration of white and grey matter structures that accompany the advance of age-related
neuropathology, the degree of faulty signalling and connectivity is likely to increase, with
further increases in variability. Taken together, this behavioural and neuroimaging research
provides evidence that supports the proposal that IIV is a sensitive indicator of
neurobiological integrity.
As well as indicating existing neuropathology, measures of IIV may also identify
individuals who are at risk of future cognitive impairment, as increased IIV may be indicative
of subthreshold impairment prior to broader cognitive decline. In addition, increased IIV may
also predict mortality as there has long been evidence for accelerated cognitive deterioration
in proximity to death (Riegel & Riegel, 1972). Given the weight of evidence, there is a
pressing need to identify individuals who are at risk of adverse outcomes as this may allow
interventions to target those most likely to benefit. Moreover, there is evidence that
treatments for conditions such as Alzheimer’s disease may be more beneficial if implemented
early in the disease process. Therefore, in additional to considering changes in variability
over time, this review also focuses on longitudinal studies that investigate the relationship
between baseline IIV and important health-related outcomes such as cognitive impairment,
dementia or mortality.
Do IIV Measures Possess Unique Properties?
Several methods have been used to compute IIV across RT trials, the most basic of
which is the raw intraindividual SD. Other measures take into account systematic variance
associated with influences such as time on task and experimental condition (e.g., adjusted
intraindividual SD), or adjust for mean level of responding (e.g., the coefficient of variation:
intraindividual SD/intraindividual mean RT). Occasionally, investigators have also used
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metrics that reflect the typically non-normal distribution of RTs such as the interquartile
range, or fitting the ex-Gaussian distribution. This produces three metrics, mu, sigma and tau,
with the latter indexing intermittently slower responses that fall into the tail of the RT
distribution.
There is typically a high correlation between measures of variability (e.g.,
intraindividual standard deviation) and central tendency (e.g., mean-RT) taken from the same
cognitive task. It has been argued that increases in IIV associated with age (Myerson,
Robertson, & Hale, 2007) and mild cognitive impairment (Phillips, Rogers, Haworth, Bayer,
& Tales, 2013) reflect a general slowing of responses. By contrast, there is evidence that IIV
provides greater differentiation in identifying persons with cognitive impairment (e.g., Dixon
et al., 2007), and it has been shown that IIV is associated with brain imaging metrics such as
white matter hyperintensites in early old age whereas mean-RT is not (e.g., Bunce et al.,
2007). Therefore, a further consideration for this review is whether IIV measures predict
outcome over and above associations accounted for by measures of central tendency.
Another important consideration is whether there is evidence that IIV adds to the
predictive power of commonly used neuropsychological assessment measures. As such tasks
are sensitive to both normal and neuropathological ageing, it is important to establish if IIV
provides unique information that may help identification of persons at risk of adverse health
outcomes. Finally, we explored whether findings varied systematically according to
methodological differences across studies, such as task complexity, the number of RT trials,
and how IIV was computed. As there is currently little consensus as to the optimum IIV
measure, we considered if there was evidence favouring a particular type of IIV metric.
Methods
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Studies were included in the present review if they appeared in an English language
peer-reviewed journal, had a longitudinal design, used IIV measures at baseline, and the
sample had a baseline mean age >55 years. This cut-off was selected in order to restrict the
review to ageing research and also encompass early old-age. Studies were excluded if they
were cross-sectional or the follow-up period was less than one year, as we were interested in
longer-term change. Studies were also excluded if they did not have measures of RT IIV (i.e.,
they only reported accuracy or mean-RT, measured IIV across a battery of cognitive tasks, or
investigated IIV in non-cognitive domains). Finally, as a systematic review of the association
between IIV, falls and gait disturbance has recently been published by our group (Graveson,
Bauermeister, McKeown, & Bunce, 2015), we excluded studies that had these outcomes.
Literature searches were completed on 17th May 2016 using the following electronic
databases: EMBASE (from 1947, OVID interface), MEDLINE (from 1946, OVID interface),
PsycINFO (from 1806, OVID interface), and Web of Science (from 1900). Three descriptors
were used. First, IIV and common variants (‘IIV’, ‘Intraindividual variability’, ‘intra-
individual variability’, ‘within person variability’, ‘reaction time variability’, ‘response time
variability’, ‘RT variability’, ‘reaction time inconsistency’, ‘response time inconsistency’,
‘RT inconsistency’), second, longitudinal research (longitudinal, ‘cohort stud*’, ‘cohort
design’, ‘follow up stud*’, ‘follow up design’, ‘prospective stud*’, ‘prospective research’,
‘prospective design’, ‘retrospective stud*’, ‘retrospective research’, ‘retrospective design’),
and third, terms relating to ageing or potential longitudinal outcomes (‘older adults’, ‘aging’,
‘ageing’, ‘neurocognitive disorder’, ‘neurodegenerative disease’, ‘dementia’, ‘Alzheimer’s
disease’, ‘mild cognitive impairment’, ‘Parkinson’s disease’, ‘Huntington’s disease’, ‘lewy
body disorder’, ‘frontotemporal lobar degeneration’, ‘mortality’, ‘death’). All descriptors
were searched for in keywords, title and abstract, and for the searches using EMBASE,
MEDLINE, and PsycInfo, Medical Subject Heading (MeSH) terms were also used where
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available. Additionally, citations in shortlisted papers and related review articles were
inspected for further relevant studies.
Investigations were assessed according to the Quality in Prognostic Studies
framework (Hayden, Cote, & Bombardier, 2006; Hayden, van der Windt, Cartwright, Cote,
& Bombardier, 2013), which evaluates studies for bias and quality according to six criteria:
Study participation, study attrition, prognostic factor measurement, outcome measurement,
study confounding, and statistical analysis and reporting. Consensus agreement was reached
for each investigation. Where studies used overlapping samples or produced conflicting
results, we drew our conclusions taking into account these criteria1.
Results
The literature search initially identified 688 studies, of which 22 met the inclusion
criteria (see Figure 1 for a flow diagram of the study selection process). After exclusions,
there were nine studies that investigated change in variability over time and 17 studies that
assessed whether IIV was associated with subsequent outcome (see Table 1 for details).
Identified outcomes were cognitive change, conversion to mild cognitive impairment or
dementia, and mortality. Three studies had a sample mean age <55 years (Bielak, Cherbuin,
Bunce, & Anstey, 2014; Deary & Der, 2005b; Shipley, Der, Taylor, & Deary, 2006), but as
these all reported analyses stratified by age group, data from the older group was included in
this review. Although we identified 22 studies that met our inclusion criteria, several of these
involved samples drawn from the same study population. Specifically, the PATH Through
Life Study (Bielak et al., 2014; Das et al., 2014), Project MIND (Bielak, Hultsch, Strauss,
MacDonald, & Hunter, 2010a, 2010b; Grand, Stawski, & MacDonald, 2016; Yao, Stawski,
Hultsch, & MacDonald, 2016), the Victoria Longitudinal Study (Bielak, Hughes, Small, &
1 Details of this evaluation are available from the corresponding author.
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Dixon, 2007; MacDonald, Hultsch, & Dixon, 2003, 2008; Whitehead, Dixon, Hultsch, &
MacDonald, 2011), the West of Scotland Twenty-07 Study (Deary & Der, 2005a, 2005b),
while two further studies used identical participants (Bayer et al., 2014; Tales et al., 2012).
The majority of these investigations fall into different sections below. However, where there
was overlap, as noted earlier, we used formalized evaluation criteria in considering the
findings.
In the following sections, first, we review studies of longitudinal change in IIV as a
function of age, and then we turn to studies in which IIV serves as a predictor of future
outcome. We then considered whether IIV was predictive of outcome over and above mean
RT derived from the same task, and assess IIV relative to traditional neuropsychological
tasks. Finally, we considered whether methodological differences across studies influenced
the findings.
Longitudinal change in variability
With the exception of a study in Parkinson’s disease patients (de Frias, Dixon, &
Camicioli, 2012), all investigations drew participants from large-scale population-based
studies of ageing. The majority of studies found that IIV increased over time (Bielak et al.,
2014; Deary & Der, 2005b; Lovden, Li, Shing, & Lindenberger, 2007; MacDonald et al.,
2003). This was consistently shown for old-old individuals (Lovden et al., 2007; MacDonald
et al., 2003) and there was evidence that the rate of change increased above 75 years of age
(Bielak et al., 2010b), although it was less clear at what age increases in IIV start. Two
studies found significant eight-year increases in IIV for individuals who were aged 55 to 59
years (Deary & Der, 2005b) or 60 to 64 years (Bielak et al., 2014) at baseline. By contrast,
Macdonald and colleagues (2003) only found six-year increase in IIV for participants aged
over 75 years, with no increase evident for those aged 55-64 or 65-74 years. In another study,
IIV did not increase over time in cognitively intact adults aged 65-84 years (de Frias, Dixon,
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Fisher, & Camicioli, 2007). However, methodological differences may underlie this result as
this study had a smaller sample, shorter follow-up duration (1.5 years), and only two
assessment points compared with three or more in the other studies.
Additional factors influencing change in IIV that have been investigated included
lifestyle activities (Bielak et al., 2007), Type II diabetes (Whitehead et al., 2011), and
genetics (Das et al., 2014). However, results were not conclusive regarding the impact of
these factors. For example, increasing IIV was associated with decreases in passive lifestyle
activities such as reading newspapers and watching television, and novel activities including
playing Bridge or completing a tax return, but not with physical or social activity, travel and
self-maintenance (Bielak et al., 2007). Also, this result was found only for the most complex
RT task, suggesting that the benefits of an engaged lifestyle are more likely to appear in more
cognitively demanding tasks. Conversely, however, the influence of Type II diabetes on
increasing variability over time was only evident in less demanding RT tasks (Whitehead et
al., 2011). Lastly, although baseline IIV was influenced by genetic variants of Catechol-O-
Methyltransferase (COMT) and Brain-Derived Neurotropic Factor (BDNF), neither genotype
primary effects nor interactions involving genotype affected the trajectory of change in IIV
(Das et al., 2014).
Associations between variability and outcome
A total of 17 studies were identified that assessed relations between variability and
outcomes that included cognitive change, mild cognitive impairment or dementia, and
mortality. Of these, four studies also reported results for change in IIV over time, and were
described in the preceding section (Bielak et al., 2010b; de Frias et al., 2012; Lovden et al.,
2007; MacDonald et al., 2003).
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Cognitive change. Six studies considered whether baseline IIV was related to change
in cognitive performance in community-dwelling adults (Bielak et al., 2010b; Ghisletta,
Fagot, Lecerf, & De Ribaupierre, 2013; Grand et al., 2016; Lovden et al., 2007; MacDonald
et al., 2003; Yao et al., 2016). In an early study, adjusting for initial IIV accounted for
cognitive change in several tasks including processing speed, memory and language
(MacDonald et al., 2003). Similarly, Lovden and colleagues (2007) found that higher trial-to-
trial variability both predicted and temporally preceded cognitive decline in verbal fluency
and perceptual speed, whereas conversely, initial cognitive performance had a negligible
influence on decline in IIV. Three additional studies investigated IIV and cognitive change
using the same dataset, with a follow-up duration of three (Bielak et al., 2010b) or six years
(Grand et al., 2016; Yao et al., 2016). In the first study, baseline IIV predicted the rate of
cognitive change on tasks involving processing speed, fluency, reasoning, memory and
language (Bielak et al., 2010b). More recent analyses over six years confirmed that baseline
IIV moderated the rate of cognitive change, but only for memory and vocabulary and not
processing speed, reasoning or fluency tasks (Grand et al., 2016). In addition, the rate of
cognitive change increased with proximity to participant attrition, and higher IIV was
associated with greater decline per year closer to attrition for memory and executive function
(Trailmaking B: Yao et al., 2016). A final study investigated the amplitude of fluctuations in
IIV and temporal dependency of responses (the relationship of each RT to the RTs that
immediately preceded it). While the temporal dependency did not predict cognitive change
(2-year follow-up adjusting for baseline scores), the amplitude of fluctuation in IIV was
associated with change in fluid intelligence, but not with change in crystallised intelligence
(Ghisletta et al., 2013). Taken together, these results suggest that baseline IIV predicts
cognitive change across multiple cognitive domains, particularly for tasks assessing fluid
abilities.
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If fluctuations in RT are a marker for cognitive decline, there is a likelihood of
covariation between change in IIV and change in cognitive performance. Consistent with this
prediction, three of the aforementioned studies found significant covariation over time
between IIV and cognition over one (Bielak et al., 2010b), two (Lovden et al., 2007) and
three years (MacDonald et al., 2003). That is, IIV was inversely related to cognitive
performance over time (higher IIV associated with lower cognitive performance), and greater
baseline variability was related to more marked subsequent cognitive decline. In addition,
when age was treated as a source of between-subject variance, it did not influence the
covariation relationship (Bielak et al., 2010b; MacDonald et al., 2003) suggesting the
association between IIV and cognitive ability is consistent across the older adult age range.
Mild Cognitive impairment and dementia. Seven studies investigated whether IIV
predicted conversion to cognitive impairment or dementia over 1.5- to 10-year periods. All
found that baseline IIV for at least one measure, was associated with outcome. In two large-
scale population-based studies, higher initial IIV was associated with an increased risk of
mild cognitive impairment over four- (Cherbuin, Sachdev, & Anstey, 2010) and five-year
(Bielak et al., 2010a) intervals. However, in the latter study, IIV measures were not able to
distinguish between persons who showed stable cognitive decline compared with those
exhibiting fluctuating performance over time. It is unclear whether these groups had the same
long-term prognosis, or whether those who show stable decline were further along the
continuum of impairment, and were more likely to progress to dementia. Two studies looked
at incident dementia in population-based samples. Baseline IIV (Kochan et al., 2016) and the
ex-Gaussian parameter tau (Balota et al., 2010), both predicted dementia conversion over 4 or
10 years, respectively. Additionally, the association was weaker but remained significant
after controlling for several established dementia risk factors. Further to these population-
based studies, variability has also been assessed in relation to future dementia in clinical
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samples. One such study assessed 1.5-year IIV change in Parkinson’s disease patients who
converted to dementia relative to non-converters and disease free controls (de Frias et al.,
2012). Increased IIV over time was evident for dementia converters, but only distinguished
the incipient Parkinson’s dementia group from the cognitively intact group and not the
Parkinson’s disease dementia converters from non-converters. From a clinical perspective,
the differentiation between Parkinson’s dementia converters and non-converters is potentially
the more important comparison if the aim is to detect individuals with Parkinson’s disease
who are more likely to cognitively deteriorate. Finally, baseline IIV was greater in patients
with amnestic MCI who subsequently converted to dementia compared to non-converters and
cognitively healthy older adults (Bayer et al., 2014; Tales et al., 2012). However, as
converters were also more cognitively impaired at baseline, it is unclear whether these results
would remain if absolute baseline differences in cognition were controlled for.
Mortality. Four studies examined whether IIV was associated with all-cause
mortality. Three reported data from older-adult samples (Batterham, Bunce, Mackinnon, &
Christensen, 2014; MacDonald et al., 2008; Shipley et al., 2006) and one from middle-aged
participants (Deary & Der, 2005a). All of these studies found that greater baseline IIV was
associated with an increased risk of death over periods of between 12 and 19 years. These
associations remained statistically significant when controlling for influences typically
associated with mortality such as socio-demographic factors, health behaviours and health
status. In addition, one study investigated the terminal decline hypothesis by modelling the
trajectories of longitudinal IIV change as a function of time to death. Decedents exhibited
increased IIV for each year closer to death and this effect was larger for those aged 80 to 95
years relative to those aged 50 to 79 years (MacDonald et al., 2003).
Comparisons with other measures
Longitudinal IIV research in older age 15
In this section we consider the potential of IIV relative to either measures derived
from the same RT task (e.g., mean or median RT). As IIV typically increases with response
slowing, it is important to consider whether IIV effects are independent of more general
slowing. Additionally, as variability measures may supplement current assessment methods,
we assess whether IIV offers potential over and above traditional neuropsychological tasks.
Measures of central tendency. The majority of studies (13 out of 17) included
measures of central tendency (mean or median RT; MRT) derived from the same cognitive
task. Seven of these reported results from models that contained both IIV and MRT measures.
Here, IIV was predictive of outcome over and above MRT in four studies (Batterham et al.,
2014; Cherbuin et al., 2010; Ghisletta et al., 2013; MacDonald et al., 2008), although this was
not universal, as two studies found superior performance for MRT (Kochan et al., 2016;
Shipley et al., 2006). In the remaining study, there was comparable performance (Deary &
Der, 2005a).
Other neuropsychological tasks. Six (out of 17) studies assessed the association
between RT measures (IIV alone, or IIV and MRT added in a single step) and outcome
relative to widely used neuropsychological tasks such as verbal recall or fluency, and IQ. In
all studies, the results indicated that RT measures offered additional predictive utility over
traditional tasks in predicting outcome, but there were mixed findings as to which RT
measure was the best predictor. For example, relative to MRT and standardized cognitive
tasks, IIV uniquely predicted MCI (Cherbuin et al., 2010). Additionally, a composite measure
of IIV, verbal recall and sustained attention performed better than the widely used Mini-
Mental State Examination (MMSE) in detecting MCI. Similarly, another investigation found
that IIV produced a reliable increment in discrimination between dementia converters and
non-converters in 14 out of 15 standardized psychomotor tasks (Balota et al., 2010). With
regard to the association with mortality, greater IIV was associated with an increased risk of
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death independent of demographic, cardiovascular disease, MRT and cognitive level
measures (MacDonald et al., 2008). Two other studies used backwards elimination to find the
best predictors of mortality. Here, simple IIV and complex MRT (Deary & Der, 2005a), and
complex MRT (Shipley et al., 2006), were retained in the model, whereas IQ and memory or
visuospatial reasoning were not. Finally, using receiver operating characteristic analyses, one
further study found that combined RT measures (IIV and MRT) compared favourably with
traditional neuropsychological measures in the prediction of incident dementia (Kochan et al.,
2016).
Methodological differences across studies
There were methodological differences between studies in terms of the cognitive task
or domain used to generate RTs, how many RT trials were included in the computation of
metrics, and how IIV was calculated from the raw RTs. This raises the question of whether
there is systematic variance in findings related to these factors, and whether there is evidence
of an optimum IIV measure.
Task complexity. A dimension upon which tasks across studies varied, was cognitive
complexity. Tasks ranged from those involving low cognitive demands (e.g., finger tapping)
to more cognitively complex tasks (e.g., task switching). Thirteen (of 17) studies used
multiple tasks or conditions of differing complexity, although two (Balota et al., 2010;
MacDonald et al., 2003) reported results based on a single composite. The findings across
studies suggested that tasks of varying complexity were all associated with outcomes
including cognitive change (Grand et al., 2016; Yao et al., 2016), cognitive impairment
(Bielak et al., 2010a; Cherbuin et al., 2010) and mortality (Batterham et al., 2014; Deary &
Der, 2005a; MacDonald et al., 2008; Shipley et al., 2006). There were two exceptions, both
of which only found significant effects for the more complex tasks (Bielak et al., 2010b;
Kochan et al., 2016). However, this was relative to the other tasks within the study rather than
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on the overall continuum of cognitive tasks. For example, in Kochan and colleagues’ (2016)
study, although choice-RT IIV and not simple-RT IIV predicted future dementia, the
differences in complexity between the two tasks was relatively small, and both were less
cognitively demanding than tasks used elsewhere. In addition, other investigations using the
same cohort and measures as Bielak and colleagues (2010b), where stronger effects for more
complex tasks were evident, found significant associations for both basic and complex
composite measures (Bielak et al., 2010a; Yao et al., 2016). In sum, it appears that the
findings for task complexity are inconsistent, and comparing across studies, the evidence
suggests that moderately complex tasks are sufficient to generate reliable metrics of IIV.
Number of trials. The majority of studies used between 20 and 60 RT trials in
computations of IIV, although one group repeat-tested the RT tasks over multiple weeks and
averaged across sessions (Bielak et al., 2010a, 2010b; Yao et al., 2016). Across studies, there
does not appear to be reliable differences arising from the number of RT trials used, or
whether the testing session was repeated. Although there was insufficient evidence to
determine whether there is an optimum number of trials, the studies included here suggest
that 20 to 60 trials were sufficient to generate reliable IIV metrics that were associated with
future outcome.
Measure of IIV. Studies also differed in how IIV metrics were computed. The
majority used either the raw SD, or adjusted SD partialling out systematic variance associated
with influences such as trial number, block, experimental condition and age group. Some
investigations however, used measures that controlled for mean level of responding (e.g.,
coefficient of variation), fitted alternative models to individual RTs (e.g., an ex-Gaussian
distribution), or used non-parametric measures (e.g., interquartile range). Where studies
reported results from multiple metrics, these tended to show converging results, with IIV
from all measures showing an association with outcome (e.g., Batterham et al., 2014;
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Cherbuin et al., 2010; Lovden et al., 2007). Across studies, the different IIV metrics tended to
produce similar results and there did not appear to be systematic variation according to the
method used to compute the IIV metric.
Discussion
This is the first systematic review to consider longitudinal change in IIV and whether
such measures predict cognitive and adverse health-related outcomes. The first main finding
was that IIV increased over time, particularly in participants aged over 75 years. Second,
greater baseline IIV was consistently associated with an increased risk of cognitive decline,
cognitive impairment, dementia, or mortality. There was also evidence that this was
independent of general slowing, and that IIV added to the predictive utility of commonly
used neuropsychological assessment tools. Lastly, findings did not vary systematically
according to methodological differences such as task complexity, number of trials and how
IIV was calculated.
The review provided clear evidence that IIV increased over time in normal ageing.
This is in line with cross-sectional studies and reviews that show higher IIV in older
compared to younger groups (Dykiert et al., 2012), and in old-old relative to young-old
individuals (Hultsch et al., 2002). There were, however, conflicting results as to the age at
which increases in IIV began. While there were consistent findings of increasing IIV in old-
old individuals, results varied across studies of younger individuals. Although theoretically it
is plausible that age-related increases in variability begin in middle age (and perhaps earlier),
further evidence supporting this possibility is clearly needed. Although beyond the scope of
the present review, a meta-analysis of longitudinal change in IIV would help elucidate these
inconsistent findings. In addition, three studies considered other influences on the trajectory
of IIV change over time including both protective (lifestyle activities) and risk factors (Type
II diabetes and COMT and BDNF gene variants) for broader cognitive decline. However,
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none of these factors consistently influenced change in IIV. Together, the findings suggest
that further work is needed to understand influences on age-related increases in IIV, and
whether such increases are changeable, for example, through lifestyle intervention.
The review also found clear evidence that greater baseline IIV was associated with
greater cognitive decline and an increased risk of MCI, dementia, or mortality over the
follow-up period. The results are consistent with cross-sectional findings of increased IIV in
populations with age-related conditions such as MCI and dementia (e.g., Christensen et al.,
2005; Dixon et al., 2007; Gorus et al., 2008). Importantly however, as the majority of studies
measured IIV at a time when participants were non-demented and cognitively intact, the
results suggest that increases in IIV may precede these adverse health-related outcomes by
several years. These findings highlights the potential for IIV as a prognostic measure that
may help identify individuals at risk of future deleterious outcomes. They are also consistent
with the proposal that IIV is a behavioural marker of neurobiological integrity (Hultsch et al.,
2000; Hultsch et al., 2008). Variability may be sensitive to early neuropathological changes
that influence attentional and executive control mechanisms (cf. Bunce et al., 2004; Bunce et
al., 1993; West et al., 2002), which precede broader cognitive dysfunction. What is also not
currently clear is whether increased IIV is related to specific neurological outcomes such as
Alzheimer’s disease, or is a universal sign of broader changes to brain integrity. Although it
is important that future research address this question, it is of note that IIV also predicted all-
cause mortality, suggesting that increased IIV is not necessarily specific to Alzheimer’s
pathology. IIV may predict mortality as neurobiological compromise may reflect broader
biological processes that themselves portend to death. However, as IIV was also associated
with an increased hazard of mortality in a middle-aged sample (Deary et al., 2006), the
mechanism linking IIV and mortality may be complex and needs to be further elucidated.
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An important consideration was whether IIV predicted outcome independently of
estimates of central tendency. Measures such as standard deviation are typically highly
correlated with mean RT taken from the same task and it has been argued that age-related
differences in IIV reflect a general slowing of responses (e.g., Myerson et al., 2007). It is
therefore appropriate to exercise caution in interpreting findings from studies that do not
control for MRT. Nonetheless, across the reviewed studies, although greater baseline MRT
was associated with an increased risk of cognitive impairment and mortality, IIV showed
consistent results across studies, and tended to be associated with outcome after adjusting for
MRT. The results suggest, therefore, that associations between IIV and outcome were not
simply related to general slowing and that IIV measures possess unique predictive utility.
This finding is consistent with cross-sectional studies that show differentiation between IIV
and MRT (e.g., Bunce et al., 2007; Dixon et al., 2007).
Although assessed in fewer studies, the results also indicated that IIV predicted
outcome over and above widely used neuropsychological tests. Again, this suggests that
variability measures offer unique information relative to other commonly used tasks, and may
therefore serve as a useful supplement to standard neuropsychological test batteries in
healthcare settings. This is an area that would benefit from further research to determine the
clinical utility of IIV, either alone or in combination with traditional measures. As an
example, Cherbuin et al. (2010) showed that variability measures in combination with other
cognitive tasks exhibited greater predictive power for cognitive impairment than the MMSE.
There were methodological variations across studies that included differences in RT
tasks, the number of RT trials used, and how the IIV metric was computed. Previous research
suggests there are greater differences associated with age (Dykiert et al., 2012) and dementia
(de Frias et al., 2007; Gorus et al., 2008) using IIV measures from more demanding tasks.
Additionally, a recent systematic review from our group suggested more sophisticated
Longitudinal IIV research in older age 21
measures of IIV may possess greater utility in understanding the relationship between IIV
and falls or gait disturbance (Graveson et al., 2015). Nonetheless, in the present review we
did not find any systematic differences in results according to task complexity, number of RT
trials, or the IIV metric used. However, the present results indicate that moderately complex
tasks, with 20 to 60 trails are sufficient to produce reliable IIV metrics. This is consistent with
a recent cross-sectional study that found that 20 trials taking approximately 52 s to administer
provided a reliable estimate of frontal white matter integrity (Bunce et al., 2013). The present
findings also suggest that it is not necessary to use multiple testing sessions, or to compute
mathematically complex measures of IIV. This is of note as such complexities would create
practical difficulties when using the measures for neuropsychological assessment in clinical
settings. Accordingly, the coefficient of variation may be appropriate in such settings, as it is
relatively straightforward to compute and takes mean RT into account.
Although there were consistent findings across studies indicating that IIV measures
were associated with future cognitive impairment or mortality, there are some caveats to this
conclusion. First, while we identified 22 studies for inclusion in this review, several of these
involved samples drawn from the same study population. This interdependence between
some studies should be kept in mind when considering the findings of this review. Second,
the samples were restricted to Western Europe, Australia, and North America and there is
clearly a need for similar work in populations from Central and South America, Africa and
Asia. Third, few studies reported metrics such as the sensitivity or specificity of IIV
measures, though where these were reported (e.g., Cherbuin et al., 2010; de Frias et al.,
2007), variability measures performed well. Lastly, none of the studies provided concrete cut-
off scores for normative performance. The absence of normative standards limits the current
clinical utility of IIV metrics. It is therefore of pressing importance that future research
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determines normal ranges for IIV and IIV change in healthy older populations as this is
central to developing the clinical utility of the measure.
Despite these considerations, having used a recognized framework to evaluate the
reviewed studies (Hayden et al., 2006; Hayden et al., 2013), there are a number of strengths
of the research that should be highlighted. First, the majority of investigations were
population based studies with large sample sizes including a broad spectrum of individuals at
risk of measured outcomes and clearly defined inclusion and exclusion criteria. Additionally,
most studies had follow-up data on more than 80% of the sample and many used statistical
procedures that took missing data into account. All of the studies included clear descriptions
of how IIV was measured and how the outcome was defined. Lastly, many of the studies also
controlled for potential confounding factors, including known risk factors for dementia and
mortality.
In conclusion, the present review considered nine studies that looked at change in IIV
over time and 17 studies that investigated whether IIV was associated with cognitive and
adverse health-related outcomes. The results suggest that increasing IIV over time is related
to normal ageing, but that more marked increases in IIV may indicate future cognitive
decline, mild cognitive impairment, dementia, or mortality. One intriguing possibility is that
IIV may provide a behavioural index of “brain frailty” arising from structural and
physiological changes in the ageing brain. As such, measures of IIV may have considerable
potential in clinical settings as they may supplement existing neuropsychological test
batteries and help identify persons for early therapeutic intervention. Measures of IIV may
therefore have considerable potential in clinical settings and offer practical advantages as
administration is quick and requires little neuropsychological training. Additionally, the tasks
often involve minimal linguistic content and may therefore be suitable for use with
individuals from diverse backgrounds. Future work is needed to develop standardized
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methods for measuring variability, with clear guidelines and norms for interpretation of
results in community-based and clinical populations.
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Table 1. Summary of studies included in the review
Reference Population, sample size (%)1, and age2 Test measure(s) Follow-up
period
Outcome measure(s) Main findings for IIV
Change in IIV
Bielak, et al.,
2014
Community dwelling older adults
(n=2115, aged 60-64 years)
IIV  ISD for SRT and 2CRT  ?ǇĞĂƌƐ ŚĂŶŐĞŝŶ//s /^ŝŶĐƌĞĂƐĞĚŽǀĞƌƚŝŵĞ ?^Zd ?ɴс ? ? ? ?Ɖф ? ? ? ? ?Zd ?ɴс ? ? ? ?Ɖф ? ? ? ? ?
Bielak, et al.,
2007
Community dwelling older adults (n=530,
aged 55-94 years)
IIV ISD for SRT, 4CRT, lexical
decision, and semantic decision
Other - Mean-RT
Lifestyle activities  physical, self-
maintenance, social, travel, passive,
integrative, and novel information
processing
6 years Change in IIV as a
function of lifestyle
activities
Change in lifestyle activities was associated with change in semantic
decision ISD (R2=.03, p=.006), with passive information processing
 ?ɴс ? ? ? ? ?pф ? ? ? ?ĂŶĚŶŽǀĞůŝŶĨŽƌŵĂƚŝŽŶƉƌŽĐĞƐƐŝŶŐ ?ɴс ? ? ? ? ?p<.05) as
unique predictors. All other Models were non-significant.
Bielak et al.,
2010b
Community dwelling older adults (n=304,
aged 64-92)
IIV  ISD for Finger tapping (Motor
composite), 4CRT, shape RT, colour
RT (basic composite), CRT 1-back,
task switching (complex composite)
Other - mean-RT
3 years Change in IIV In full sample, none of the ISD composites increased over time
(average slopes did not differ from zero).
For Motor ISD, there were no age differences on rate of change. For
Basic ISD and Complex ISD, the rate of change increased with age
over 75 years (slope increase of .03 for every year over 75, pdiff
<.001)
Das et al.,
2014
Community dwelling older adults (n=400,
aged 60-64 years)
IIV  ISD for SRT and 2CRT
Other - mean-RT
Genotype - COMT*MET- or
COMT*MET+, BDNF*MET- or
BDNF*MET+
8 years Change IIV as a function
of genotype
ISD increased over time, but the trajectory of change was not
different for the genotype groups.
Deary & Der,
2005b
Community dwelling older adults (n=673,
aged 54-59 years)
IIV  raw SD for SRT and CRT; SD
adjusted for mean-RT
Other- Mean-RT
8 years Change in IIV Using raw SD, IIV increased over time (statistics not reported)
Using SD adjusted for mean-RT, IIV remained stable or declined
slightly.
de Frias et
al., 2007
PD dementia converters (n=10, aged 66-
84 years) non-converters (n=21, aged 65-
77) and CH adults (n=43, aged 65-84
years)
IIV ISD for SRT, 2CRT, 4CRT, 8CRT
Other  mean-RT
1.5 years Change in IIV Significant Group x Time interaction (p<.01); PD dementia
converters became more variable over time while the non-
converters and CD groups did not.
Lovden et al.,
2007
Community-dwelling older adults
(n=447, aged 70-102 years)
IIV  CV for Identical Pictures
Other - Mean-RT
13 years Change in IIV There was an average 2-year increase in CV (p<.05).
Older age reliably predicted greater change in variability.
MacDonald
et al., 2003
Community dwelling older adults (n=446
(59%), aged 55-89 years)
IIV  ISD for SRT, 2CRT, 4CRT, 8CRT,
lexical decision, and semantic
decision
6 years Change in IIV ISD increased over time for semantic decision but declined for CRT.
There were significant Age x Wave interactions for SRT (p<.05),
lexical decision (p<.01), and semantic decision (p<.01). ISD remained
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Reference Population, sample size (%)1, and age2 Test measure(s) Follow-up
period
Outcome measure(s) Main findings for IIV
stable for those aged 54-65 and 64-75 years, and increased for
individuals aged 75-89 years.
Whitehead
et al., 2011
Community-dwelling older adults (N=330
(71%), aged 53-90 years) with type II
diabetes (n=30) and CH controls (n=302).
IIV  ISD for SRT, 2CRT, 4CRT, 8CRT,
lexical decision, and semantic
decision
Other  mean-RT
3 years Change in IIV There were significant effects of time on ISD for 2CRT (p<.001 (one
tailed)), lexical decision (p<.05 (one tailed)), and semantic decision
(p<.05 (one tailed)). Time x type II diabetes interactions were only
evident for 2CRT (p<.05).
Outcome  Cognitive change
Bielak et al.,
2010b
Community dwelling older adults (n=304,
aged 64-92)
IIV  ISD for Finger tapping (Motor
composite), 4CRT, shape RT, colour
RT (basic composite), 4CRT 1-back,
task switching (complex composite)
Other - mean-RT
3 years Change in cognitive
functioning (digit
symbol, letter series,
word recall, similarities,
vocabulary)
Complex ISD composite predicted cognitive change (digit symbol,
p<.001; letter series, p<.01; word recall, p<.01, vocabulary, p<.05)
There was significant 1-year covariance (p<.01) between ISD
composites and cognitive measures in 10 of 15 models; When IIV
was high, cognitive performance was correspondingly low.
Ghisletta et
al., 2013
Community dwelling older adults (n=165,
aged 59-89)
IIV  detrended ISD (ISDei-1),
ĂƵƚŽƌĞŐƌĞƐƐŝǀĞĐŽĞĨĨŝĐŝĞŶƚ ?ʔ1) for
SRT
Other - Mean-RT
2 years Change in fluid and
crystallized intelligence
(Ravens progressive
matrices and Mill Hill
vocabulary)
ISDei-1 predicted Raven score at Time 2 when controlling for Raven
score at Time 1 (pс ? ? ? ? ?EŽƐŝŐŶŝĨŝĐĂŶƚĂƐƐŽĐŝĂƚŝŽŶĨŽƌʔ1,or Mill Hill
score at Time 2 controlling for Time 1 score.
Grand et al.,
2016
Community dwelling older adults (n=304,
aged 64-92)
IIV  ISD for 4CRT, 4CRT 1-back
Other  slope of change in ISD over
five testing session two-weeks apart.
6 years Change in cognitive
functioning (digit
symbol, letter series,
word recall, similarities,
vocabulary)
Baseline 4CRT ISD moderated rates of cognitive change for word
recall and vocabulary (p<.05). 4CRT 1-back ISD moderated rate of
change for word recall only (p<.05).
Lovden et al.,
2007
Community-dwelling older adults
(n=447, aged 70-102 years)
IIV  CV for Identical Pictures
Other - Mean-RT
13 years Change in cognitive
functioning (digit
letters and verbal
fluency)
Higher trial-to-trial variability preceded and predicted greater
cognitive decline in perceptual speed and verbal fluency
Significant correlations between 2-year change in IIV and change in
digit letters (r=-.68, p<.05) and fluency (r=-.82, p<.05)
MacDonald
et al., 2003
Community dwelling older adults (n=446
(59%), aged 55-89 years)
IIV  ISD for SRT, 2CRT, 4CRT, 8CRT,
lexical decision, and semantic
decision
6 years Change in cognitive
functioning (identical
pictures, computation
span, letter series,
word recall, story
recall, vocabulary)
Controlling for baseline IIV attenuated the variance associated with
cognitive change (between 85.7 and 96.5% attenuation).
Significant 3-year time-varying covariation was observed. Increasing
inconsistency was associated with declining cognitive performance
for 5 of 6 measures.
Yao et al.,
2016
Community dwelling older adults (n=304,
aged 64-92)
IIV  ISD for 4CRT, shape RT, colour
RT (basic composite), 4CRT 1-back,
task switching (complex composite)
6 years Change in cognitive
functioning (TMT parts
A and B, free recall,
WAIS III block design,
vocabulary)
Higher IIV was associated with greater decline per year closer to
study attrition (Basic ISD composite, word recall p<.001; Complex
ISD composite, word recall p<.001, TMT-B p<.001). Other outcomes
were non-significant.
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Reference Population, sample size (%)1, and age2 Test measure(s) Follow-up
period
Outcome measure(s) Main findings for IIV
Outcome  Cognitive impairment or dementia
Balota et al.,
2010
Healthy older adults (n=37
(100%) classified as converters (n=12,
M=81.7 years) and non-converters
(n=25,M=77.3 years)
IIV - Ex-Gaussian tau parameter for
Stroop task (congruent and
incongruent combined)
Other  Mean-RT, Errors for Stroop
task, standardized cognitive tests3
Average of
7.6  10
years
Dementia of
Alzheimers type
 ?Zш ? ? ? ? ?
Using Cox Proportional Hazard Analysis tau was associated with
dementia conversion, p<.01; OR 1.009, 95% CI=1.003-1.012).
Tau produced a reliable increment in discrimination between
converters and non-converters over 14/15 of the psychometric
measures (p<0.05)
Bayer et al.,
2014
Patients with amnestic MCI (n=39 (87%)
classified as converters (n=13,M=75±7
years) and non-converters (n=26,
M=72±6 years) and cognitively heathy
adults (n=31,M=73±5.0 years)
IIV-IQR for Posner exogenous cuing
task
Other  Median RT, attentional
disengagement, inhibition of return,
MMSE.
2.5 years Dementia (NINCDS-
ADRDA criteria)
Raised baseline IQR in amnestic MCI converters compared with CH
adults (p<.026) and non-converters (p<.008) for all cue target
intervals.
Bielak et al.,
2010a
Community-dwelling older adults (n=212
(70%) aged 64-92 years)
IIV  ISD for Finger tapping (Motor
composite), 4CRT, shape RT, colour
RT (basic composite), 4CRT 1-back,
task switching (complex composite)
Other - mean-RT
5 years Change in cognitive
status (stable intact,
fluctuating, stable
decline and stable
CIND-cognitive
impairment no
dementia)
Baseline ISD was raised in the fluctuating and declining groups. Basic
ISD, fluctuating vs intact (p<.05; OR 1.29) declining vs intact (p<.01,
OR=1.61). Complex ISD, fluctuating vs intact (p<.01; OR 1.20)
declining vs intact (p<.01; OR=1.32).
Cherbuin et
al., 2010
Community-dwelling older adults
(n=2082 (87%) aged 60-64 years)
IIV  Mean absolute residuals (MAR)
and mean independent residuals
(MIV) for SRT and CRT
Other - mean-RT for SRT and CRT,
standardized cognitive tasks4
 ?ǇĞĂƌƐ D/ ?Zш ? ? ? ?ĂŶǇŵŝůĚ
cognitive deficits (any-
MCD)
SRT MAR (p=.001), SRT MIV (p<.002) and CRT MIV (p<.046) were all
associated with MCI, CDR 0.5, and any-MCD.
In the fully adjusted Model (all cognitive tasks, MRT and MAR) SRT
MAR was associated with MCI (p<.001; OR 9.27, 95% CI=1.04-82.52),
CDR 0.5 (p=.008; OR 10.85, 95% CI=1.82-64.39) and any-MCD
(p=.003; OR 7.52, 95% CI=1.96-28.89).
de Frias et
al., 2012
PD patients (n=31 (100%) aged 65-84
years) classified as converters (n=10) or
non-converters (n=21), and cognitively
healthy adults (n=43, aged 65-84 years)
IIV  18-month change in ISD for SRT,
2CRT, 4CRT, 8CRT
Other  18-month change in mean-
RT
1.5 years Dementia or cognitive
impairment
Significant Group x Time interaction (p<.01); PD dementia
converters became more variable over time while the other groups
did not.
Using logistic regression, change in SRT ISD was a predictor of group
membership between PD converters and CH (p<.01; OR 1.38, 95%
CI=1.05-1.83) but not between PD converters and non-converters.
Kochan et
al., 2016
Community dwelling older adults (n=861
(83%), aged 70-90 years)
IIV  ISD for SRT and CRT
Other  Mean-RT, Standardized
cognitive tests5
4 years Dementia Greater complex IIV was associated with an increased hazard of
incident dementia (p=.003; HR=1.43). This remained significant
when adjusting for clinical or medical covariates in separate models.
After adjusting for mean-RT, incremental effects of IIV were not
significant.
Tales et al.,
2012
Same sample at Bayer et al. (2014) IIV - IQR for visual attention
Other - Median RT and phasic
alerting (no cue-cued RT)
2.5 years Dementia (NINCDS-
ADRDA criteria)
Raised IQR in the amnestic MCI converters compared with non-
converters (p=.001). There was no significant difference between
aMCI non-converters and the CH group.
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Reference Population, sample size (%)1, and age2 Test measure(s) Follow-up
period
Outcome measure(s) Main findings for IIV
Outcome  Mortality
Batterham et
al, 2014
Community based older adults (n=825
for SRT and n=802 for CRT, aged 70-97)
IIV  raw SD, CV, and ISD for SRT and
2CRT
Other  mean-RT
17 years All-cause mortality Greater IIV (all measures) was associated with an increased hazard
of mortality (p<.001, HR<1.14). This remained significant for all SRT
ŵĞĂƐƵƌĞƐ ?Ɖч ? ? ? ?ĂŶĚĨŽƌZdƌĂǁ^ĂŶĚ/^ ?pч ? ? ? ?ǁŚĞŶ
adjusting for covariates. The association remained significant for SRT
IIV measures (pч ? ? ? ?ǁŚĞŶĂĚĚŝƚŝŽŶĂůůǇĂĚũƵƐƚŝŶŐĨŽƌŵĞĂŶ ?Zd ?
Deary & Der,
2005a
Community dwelling middle-aged adults
(n=898, aged 54-59)
IIV  raw SD for SRT and 4CRT
Other - mean-RT
14 years All-cause mortality Greater raw SD was associated with an increased hazard of
mortality (SRT, p<.0001, HR=1.29, 95% CI=1.15-1.44; CRT, p=.023,
HR=1.17, 95% CI=1.02-1.34). Effects remained significant when
adjusting for covariates (SRT, p<.0001, CRT, p=.048).
There were no independent effects in fully adjusted model (mean-
RT, raw SD, IQ and covariates). Using backwards elimination SRT SD
and CRT mean-RT were retained in the model.
MacDonald
et al., 2008
Community dwelling older adults (n=707
(70%), aged 55-85 years)
IIV  ISD for lexical decision and
semantic decision.
Other- mean-RT, Cognitive
performance level6
12 years All-cause mortality Greater ISD in decedents compared with survivors (p<.001).
ISD predicted mortality when adjusting for covariates and all
cognitive tasks (Semantic decision, p<.01, lexical decision, p<.05).
Semantic decision also predicted mortality after adjusting for mean-
RT (pч ? ? ? ?
Shipley et al.,
2006
Community dwelling adults (n=7,414
aged 18-99 years, n=963 aged 60+ years)
IIV  SD for SRT and 4CRT
Other  mean-RT, verbal declarative
memory and visuospatial reasoning
19 years All-cause Mortality Controlling for age and sex, SRT (HR=1.09) and CRT (HR=1.07) raw
SD was associated with mortality in 60+ group. This remained
significant for SRT (HR=1.03) when adjusting for all covariates.
Using backwards elimination (SD, mean-RT, memory, and reasoning)
CRT mean-RRT was the only predictor that was retained.
1 Longitudinal sample size; (%) refers to percentage of baseline sample included in analyses. 2Age at baseline
3 Logical memory, digit span forward and backward, trail making test parts A and B, WAIS-R information, WIAS-R block design, WAIS-R digit symbol, Benton delay, Benton copy, Boston
naming test, crossing off, mental control, associate recall, letter fluency
4 MMSE, immediate and delayed recall, digit span backwards, spot-the-word, symbol digit modality test
5 Logical memory - delayed, Rey auditory verbal learning test- delayed, category fluency, coding, WAIS-R block design, Benton visual retention, trailmaking test parts A and B, Boston naming
test, letter fluency
6Working memory (sentence construction, listening span, computation span), episodic memory (word list recall, story recall), semantic memory (world fact recall, recognition vocabulary)
BDNF= Brain-Derived Neurotropic Factor; CDR=clinical dementia rating; CH=cognitively healthy; 95% CI=95% confidence interval; COMT= Catechol-O-Methyltransferase; CRT=complex
reaction time; CV=coefficient of variation; HR=hazard ratio; IIV=intraindividual variability; ISD=intraindividual standard deviation; IQR=interquartile range; MCI=Mild Cognitive Impairment;
MMSE=Mini Mental State Examination; PD=Parkinsons disease; SD=standard deviation; SRT=simple reaction time; TMT=trailmaking test.
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